Study Finds J&J's Natrecor Increases Death Risk (Reuters)


Reuters - Johnson & Johnson's Natrecor heart
failure treatment may be linked to a greater risk of death when
compared with standard therapy, according to a review of data
in a prominent medical journal on Tuesday.

Read more...